Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Mar;3(2):87-98.
doi: 10.1177/1756283X09356590.

Evaluation and management of dyspepsia

R Christopher Harmon  1 , David A Peura
Affiliations

Evaluation and management of dyspepsia

R Christopher Harmon et al. Therap Adv Gastroenterol. 2010 Mar.

Abstract

Dyspepsia is a common clinical problem seen by both primary care physicians and gastroenterologists. Initial evaluation should focus on the identification and treatment of potential causes of symptoms such as gastroesophageal reflux disease (GERD), peptic ulcer disease, and medication side effects but also on recognizing those at risk for more serious conditions such as gastric cancer. This manuscript discusses the evaluation and management of dyspepsia including the role of proton-pump inhibitors, treatment of Helicobacter pylori, and endoscopy. Finally, treatment of refractory functional dyspepsia is addressed.

Keywords: Helicobacter pylori; dyspepsia; endoscopy; evaluation; functional dyspepsia; management; proton-pump inhibitor.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Schematic diagram of the management of dyspepsia. EGD, esophagogastroduodenoscopy; NSAIDS, nonsteroidal anti-inflammatory drugs; GERD, gastroesophogeal reflux disease; PPI, proton pump inhibitor; IBS, irritable bowel syndrome. Note: diagnostic algorithm may differ based on regional cancer risk, gender, and age of patient at presentation.
See this image and copyright information in PMC

References

    1. Agreus L., Svardsudd K., Nyren O., Tibblin G. (1995) Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 109: 671–680 - PubMed
    1. Arents N.L., Thijs J.C., van Zwet A.A., Oudkerk Pool M., Gotz J.M., van de Werf G.T., et al. (2003) Approach to treatment of dyspepsia in primary care: a randomized trial comparing ‘test-and-treat’ with prompt endoscopy. Arch Intern Med 163: 1606–1612 - PubMed
    1. Beattie D.T., Smith J.A., Marquess D., Vickery R.G., Armstrong S.R., Pulido-Rios T., et al. (2004) The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo. Br J Pharmacol 143: 549–560 - PMC - PubMed
    1. Behar J., Corazziari E., Guelrud M., Hogan W., Sherman S., Toouli J. (2006) Functional gallbladder and sphincter of oddi disorders. Gastroenterology 130: 1498–1509 - PubMed
    1. Blackshaw G.R., Barry J.D., Edwards P., Allison M.C., Lewis W.G. (2003) Open-access gastroscopy is associated with improved outcomes in gastric cancer. Eur J Gastroenterol Hepatol 15: 1333–1337 - PubMed

LinkOut - more resources